Publication | Closed Access

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Lymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicineImmunologyPathologyImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentSmall Lymphocytic LymphomaImmunotherapyOncologyRadiation Oncology